Apixaban or Vitamin K Antagonists for Stroke Prevention in Patients With Atrial Fibrillation on Hemodialysis: Results of the Randomized Axadia-AFNET 8 Trial

被引：0
|
作者：
Reinecke, Holger [1 ]
Bauersachs, Rupert [2 ]
Breithardt, Gunter [3 ]
Engelbertz, Christiane [3 ]
Gerss, Joachim [4 ]
Gaerlich, Dennis [4 ]
Juergensmeyer, Sabine [5 ]
Wanner, Christoph [6 ]
Kirchhof, Paulus [7 ]
机构：
[1] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[2] Agaples Bethanien Hosp, Med Care Cntr, Frankfurt, Germany
[3] Univ Hosp Muenster, Dept Cardiol, Munster, Germany
[4] Univ Munster, Inst Biostat & Clin Rsch, Munster, Germany
[5] Atrial Fibrillat Network, Munster, Germany
[6] Univ Hosp, Div Nephrol, Dept Med, Wurzburg, Germany
[7] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany
来源：
CIRCULATION | 2022年 / 146卷 / 25期
关键词：
atrialfibrillation; apixaban; vitamin K antagonist; hemodialysis; randomized; controlled trial; stroke prevention;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18519
引用
收藏
页码：E589 / E590
页数：2
相关论文
共 50 条
  • [31] Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation
    Andreas Zirlik
    Christoph Bode
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 365 - 379
  • [32] Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry
    Haeusler, Karl Georg
    Gerth, Andrea
    Limbourg, Tobias
    Tebbe, Ulrich
    Oeff, Michael
    Wegscheider, Karl
    Treszl, Andras
    Ravens, Ursula
    Meinertz, Thomas
    Kirchhof, Paulus
    Breithardt, Guenter
    Steinbeck, Gerhard
    Nabauer, Michael
    BMC NEUROLOGY, 2015, 15
  • [33] Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation A Meta-Analysis of Randomized Controlled Trials
    Kumar, Shashi
    Danik, Stephan B.
    Altman, Robert K.
    Barrett, Conor D.
    Lip, Gregory Y. H.
    Chatterjee, Saurav
    Roubin, Gary S.
    Natale, Andrea
    Danik, Jacqueline S.
    CARDIOLOGY IN REVIEW, 2016, 24 (05) : 218 - 223
  • [34] Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
    Xu, Wenlin
    Lv, Meina
    Wu, Shuyi
    Jiang, Shaojun
    Zeng, Zhiwei
    Fang, Zongwei
    Qian, Jiafen
    Chen, Mingrong
    Chen, Jiana
    Zhang, Jinhua
    CARDIOVASCULAR DRUGS AND THERAPY, 2023, 37 (02) : 363 - 377
  • [35] Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
    Giorgi, Mariano Anibal
    Caroli, Christian
    Giglio, Norberto Damian
    Micone, Paula
    Aiello, Eleonora
    Vulcano, Cristina
    Blanco, Julia
    Donato, Bonnie
    Quevedo, Joaquin Mould
    HEALTH ECONOMICS REVIEW, 2015, 5
  • [36] Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
    Mariano Anibal Giorgi
    Christian Caroli
    Norberto Damian Giglio
    Paula Micone
    Eleonora Aiello
    Cristina Vulcano
    Julia Blanco
    Bonnie Donato
    Joaquin Mould Quevedo
    Health Economics Review, 5
  • [37] Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study
    Paschke, Lena M.
    Klimke, Kerstin
    Altiner, Attila
    von Stillfried, Dominik
    Schulz, Maike
    BMC MEDICINE, 2020, 18 (01)
  • [38] Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
    Avezum, Alvaro
    Lopes, Renato D.
    Schulte, Phillip J.
    Lanas, Fernando
    Gersh, Bernard J.
    Hanna, Michael
    Pais, Prem
    Erol, Cetin
    Diaz, Rafael
    Cecilia Bahit, M.
    Bartunek, Jozef
    De Caterina, Raffaele
    Goto, Shinya
    Ruzyllo, Witold
    Zhu, Jun
    Granger, Christopher B.
    Alexander, John H.
    CIRCULATION, 2015, 132 (08) : 624 - 632
  • [39] Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation
    Diener, Hans-Christoph
    Hankey, Graeme J.
    Easton, J. Donald
    Lip, Gregory Y. H.
    Hart, Robert G.
    Caso, Valeria
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0I) : I13 - I21
  • [40] Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
    Pradelli, Lorenzo
    Calandriello, Mario
    Di Virgilio, Roberto
    Bellone, Marco
    Tubaro, Marco
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2014, 15 : 5 - 14
12345